BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Marteene W, Winckel K, Hollingworth S, Kisely S, Gallagher E, Hahn M, Ebdrup BH, Firth J, Siskind D. Strategies to counter antipsychotic-associated weight gain in patients with schizophrenia. Expert Opin Drug Saf 2019;18:1149-60. [PMID: 31564170 DOI: 10.1080/14740338.2019.1674809] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Spokes J, Hollingworth S, Winckel K, Kisely S, Baker A, Cosgrove P, Siskind D. Metformin reduces 12-month change in body weight among people newly commenced on clozapine: a retrospective naturalistic cohort study. Ther Adv Psychopharmacol 2021;11:20451253211000609. [PMID: 33796266 DOI: 10.1177/20451253211000609] [Reference Citation Analysis]
2 Nielsen RE, Banner J, Jensen SE. Cardiovascular disease in patients with severe mental illness. Nat Rev Cardiol 2021;18:136-45. [PMID: 33128044 DOI: 10.1038/s41569-020-00463-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
3 D'Alessandro C, Benedetti A, Di Paolo A, Giannese D, Cupisti A. Interactions between Food and Drugs, and Nutritional Status in Renal Patients: A Narrative Review. Nutrients 2022;14:212. [PMID: 35011087 DOI: 10.3390/nu14010212] [Reference Citation Analysis]
4 Boyda HN, Pham M, Huang J, Ho AA, Procyshyn RM, Yuen JWY, Honer WG, Barr AM. Antipsychotic Drug-Induced Increases in Peripheral Catecholamines are Associated With Glucose Intolerance. Front Pharmacol 2022;13:765905. [PMID: 35242029 DOI: 10.3389/fphar.2022.765905] [Reference Citation Analysis]
5 Yang Y, Xie P, Long Y, Huang J, Xiao J, Zhao J, Yue W, Wu R. Previous exposure to antipsychotic drug treatment is an effective predictor of metabolic disturbances experienced with current antipsychotic drug treatments. BMC Psychiatry 2022;22:210. [PMID: 35313842 DOI: 10.1186/s12888-022-03853-y] [Reference Citation Analysis]
6 Kassem M, Haddad C, Daccache C, Hayek C, Hallit S, Kazour F. Factors associated with overweight and obesity in Lebanese male patients with schizophrenia. Perspect Psychiatr Care 2021;57:1347-55. [PMID: 33244768 DOI: 10.1111/ppc.12697] [Reference Citation Analysis]
7 Liao X, Ye H, Si T. A Review of Switching Strategies for Patients with Schizophrenia Comorbid with Metabolic Syndrome or Metabolic Abnormalities. Neuropsychiatr Dis Treat 2021;17:453-69. [PMID: 33603382 DOI: 10.2147/NDT.S294521] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 Panizzutti B, Bortolasci CC, Spolding B, Kidnapillai S, Connor T, Richardson MF, Truong TTT, Liu ZSJ, Gray L, Kim JH, Dean OM, Berk M, Walder K. Biological Mechanism(s) Underpinning the Association between Antipsychotic Drugs and Weight Gain. J Clin Med 2021;10:4095. [PMID: 34575210 DOI: 10.3390/jcm10184095] [Reference Citation Analysis]
9 Dubath C, Piras M, Gholam M, Laaboub N, Grosu C, Sentissi O, Gamma F, Solida A, von Gunten A, Conus P, Eap CB. Effect of Quetiapine, from Low to High Dose, on Weight and Metabolic Traits: Results from a Prospective Cohort Study. Pharmacopsychiatry 2021. [PMID: 34388836 DOI: 10.1055/a-1525-2820] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Siskind D, Gallagher E, Winckel K, Hollingworth S, Kisely S, Firth J, Correll CU, Marteene W. Does Switching Antipsychotics Ameliorate Weight Gain in Patients With Severe Mental Illness? A Systematic Review and Meta-analysis. Schizophr Bull 2021;47:948-58. [PMID: 33547471 DOI: 10.1093/schbul/sbaa191] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
11 Konishi T, Fujiogi M, Michihata N, Tanaka-Mizutani H, Morita K, Matsui H, Fushimi K, Tanabe M, Seto Y, Yasunaga H. Breast cancer surgery in patients with schizophrenia: short-term outcomes from a nationwide cohort. Br J Surg 2021;108:168-73. [PMID: 33711128 DOI: 10.1093/bjs/znaa070] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Burin LM, Hahn MK, da Rocha NS, van Amelsvoort T, Bartels-Velthuis AA, Bruggeman R, de Haan L, Schirmbeck F, Simons CJP, van Os J, Cahn W. Long-term treatment of antipsychotics and combined therapy with other psychotropic medications inducing weight gain in patients with non-affective psychotic disorder: Evidence from GROUP, a longitudinal study. Psychiatry Res 2022;314:114680. [PMID: 35753222 DOI: 10.1016/j.psychres.2022.114680] [Reference Citation Analysis]
13 Regan AS, Valcourt SC. Metabolic Syndrome in Bipolar Disorder: Review and Management. Psychiatric Annals 2020;50:334-9. [DOI: 10.3928/00485713-20200713-01] [Reference Citation Analysis]
14 Bak M, Drukker M, Cortenraad S, Vandenberk E, Guloksuz S. Antipsychotics result in more weight gain in antipsychotic naive patients than in patients after antipsychotic switch and weight gain is irrespective of psychiatric diagnosis: A meta-analysis. PLoS One 2021;16:e0244944. [PMID: 33596211 DOI: 10.1371/journal.pone.0244944] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Vasileva SS, Tucker J, Siskind D, Eyles D. Does the gut microbiome mediate antipsychotic-induced metabolic side effects in schizophrenia? Expert Opin Drug Saf 2022. [PMID: 35189774 DOI: 10.1080/14740338.2022.2042251] [Reference Citation Analysis]
16 Tan MSA, Honarparvar F, Falconer JR, Parekh HS, Pandey P, Siskind DJ. A systematic review and meta-analysis of the association between clozapine and norclozapine serum levels and peripheral adverse drug reactions. Psychopharmacology (Berl). 2021;238:615-637. [PMID: 33410989 DOI: 10.1007/s00213-020-05746-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
17 Zhang C, Li H, Yan Y, Zhang X, Tu Z. 5:2 intermittent fasting tapers food intake in the refeeding state and ameliorates metabolic disturbances in mice exposed to olanzapine. Front Psychiatry 2022;13:926251. [DOI: 10.3389/fpsyt.2022.926251] [Reference Citation Analysis]
18 Stogios N, Maksyutynska K, Navagnanavel J, Sanches M, Powell V, Gerretsen P, Graff-Guerrero A, Chintoh AF, Foussias G, Remington G, Hahn MK, Agarwal SM. Metformin for the prevention of clozapine-induced weight gain: A retrospective naturalistic cohort study. Acta Psychiatr Scand 2022. [PMID: 35726126 DOI: 10.1111/acps.13462] [Reference Citation Analysis]
19 Ebdrup BH, Knop FK. Weight gain on antipsychotics - A perfect storm of complex pathophysiology and psychopharmacology. Acta Psychiatr Scand 2021;144:521-3. [PMID: 34587287 DOI: 10.1111/acps.13376] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Tan MSA, Parekh HS, Pandey P, Siskind DJ, Falconer JR. Nose-to-brain delivery of antipsychotics using nanotechnology: a review. Expert Opin Drug Deliv 2020;17:839-53. [PMID: 32343186 DOI: 10.1080/17425247.2020.1762563] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
21 Boyda HN, Ho AA, Tse L, Procyshyn RM, Yuen JWY, Kim DD, Honer WG, Barr AM. Differential Effects of Acute Treatment With Antipsychotic Drugs on Peripheral Catecholamines. Front Psychiatry 2020;11:617428. [PMID: 33335492 DOI: 10.3389/fpsyt.2020.617428] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
22 Shields GE, Camacho E, Farragher T, Clarkson P, Verma A, Davies LM. Acknowledging Patient Heterogeneity in Economic Evaluations in Schizophrenia: A Systematic Review. Value Health 2022;25:147-56. [PMID: 35031093 DOI: 10.1016/j.jval.2021.07.001] [Reference Citation Analysis]
23 Libowitz MR, Nurmi EL. The Burden of Antipsychotic-Induced Weight Gain and Metabolic Syndrome in Children. Front Psychiatry 2021;12:623681. [PMID: 33776816 DOI: 10.3389/fpsyt.2021.623681] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Yong N, Pan J, Li X, Yu L, Hou X. Influencing factors of obesity in community patients with deficit schizophrenia: a cross-sectional study. Eur J Med Res 2022;27:90. [PMID: 35690794 DOI: 10.1186/s40001-022-00706-y] [Reference Citation Analysis]
25 Cernea S, Dima L, Correll CU, Manu P. Pharmacological Management of Glucose Dysregulation in Patients Treated with Second-Generation Antipsychotics. Drugs 2020;80:1763-81. [PMID: 32930957 DOI: 10.1007/s40265-020-01393-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]